If you look at the possibility of having a quarter ending in June with around 500,000 more revenue than expenses then taking that figure and annualising it at 2m and a PE ratio of 15 (the average)makes the share worth around 54c which is where we were a month ago prior to any announcements.
Interesting isnt it.
Shes a headscratcher this one, eh, brothers (and sisters)
Ann: Cellmid Secures Bloomingdales USA Partnership for Evolis, page-32
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
